Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
March 9, page 16: TaiGen Biotechnology has initiated Phase II clinical trials of burixafor in China for use in chemotherapy sensitization in leukemia patients. The trials are not yet complete.
A source of aggravation for me in reading the literature, newspapers, and e-mails today is the use of acronyms without identifying what the letters represent. I checked out my most recent issue of C&EN (Jan. 19) to see how often acronyms are used and, if so, identified. It was a most pleasant surprise that there were 13 acronyms used throughout the magazine and all were appropriately identified.
A few are listed here as examples of the consistency of your style: SOCMA—Society of Chemical Manufacturers & Affiliates (page 3); ROMP—ring-opening metathesis polymerization (page 6); STEM—science, technology, engineering, and mathematics (page 8); and GMO—genetically modified organism (page 11).
C&EN’s editorial style has set a fine example for the chemical profession.
John L. Neumeyer
Wayland, Mass.
You might also like...
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X